StockDuty ← Dashboard Aug 11, 2026 03:29 PM ET
SignalCorporate

Autolus Therapeutics' AUCATZYL Q2 Revenue Surges 119%; Boosts FY26 Outlook

Revenue surge of 119% plus raised FY26 outlook drove corporate alert.

What changed
Revenue surge of 119% plus raised FY26 outlook drove corporate alert.
Why it matters
Revenue surge of 119% plus raised FY26 outlook drove corporate alert. — impact context not separately stored; see What changed.
Sources
eodhd
Related signals
FITCH AFFIRMS CHINA CREDIT RATING AT 'A' →FITCH ISSUES NEW STATEMENT AND OUTLOOK ON U.S . CREDIT RATING DEBT WARNING IN FIRST PARAGRAPH . →$FMX →